The first direct activator of BAX, a pro-apoptotic member of the BCL-2 family, has been recently identified. Herein, a structure-based lead optimization turned out into a small series of analogues, where 8 is the most potent compound published so far. 8 was used as pharmacological tool to ascertain, for the first time, the anticancer potential of BAX direct activators and the obtained results would suggest that BAX direct activators are potential future anticancer drugs rather than venoms.

Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents / Stornaiuolo, Mariano; La Regina, Giuseppe; Passacantilli, Sara; Grassia, Gianluca; Coluccia, Antonio; LA PIETRA, Valeria; Giustiniano, Mariateresa; Cassese, Hilde; DI MARO, Salvatore; Brancaccio, Diego; Taliani, Sabrina; Ialenti, Armando; Silvestri, Romano; Martini, Claudia; Novellino, Ettore; Marinelli, Luciana. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 58:5(2015), pp. 2135-48-2148. [10.1021/jm501123r]

Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents

STORNAIUOLO, MARIANO
Primo
;
GRASSIA, GIANLUCA;LA PIETRA, VALERIA;GIUSTINIANO, MARIATERESA;CASSESE, HILDE;DI MARO, SALVATORE;BRANCACCIO, DIEGO;IALENTI, ARMANDO;NOVELLINO, ETTORE;MARINELLI, LUCIANA
2015

Abstract

The first direct activator of BAX, a pro-apoptotic member of the BCL-2 family, has been recently identified. Herein, a structure-based lead optimization turned out into a small series of analogues, where 8 is the most potent compound published so far. 8 was used as pharmacological tool to ascertain, for the first time, the anticancer potential of BAX direct activators and the obtained results would suggest that BAX direct activators are potential future anticancer drugs rather than venoms.
2015
Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents / Stornaiuolo, Mariano; La Regina, Giuseppe; Passacantilli, Sara; Grassia, Gianluca; Coluccia, Antonio; LA PIETRA, Valeria; Giustiniano, Mariateresa; Cassese, Hilde; DI MARO, Salvatore; Brancaccio, Diego; Taliani, Sabrina; Ialenti, Armando; Silvestri, Romano; Martini, Claudia; Novellino, Ettore; Marinelli, Luciana. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 58:5(2015), pp. 2135-48-2148. [10.1021/jm501123r]
File in questo prodotto:
File Dimensione Formato  
jm501123r.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Accesso privato/ristretto
Dimensione 6.72 MB
Formato Adobe PDF
6.72 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/612348
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 31
social impact